Literature DB >> 6342778

Effects of the beta-adrenoceptor-blocking agent Sotalol on ventricular arrhythmias in patients with chronic ischemic heart disease. A placebo-controlled, double-blind cross-over study.

D Burckhardt, M Pfisterer, A Hoffmann, F Burkart, H Emmenegger, M Jost, P Bolli, F R Buehler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6342778     DOI： 10.1159/000173639

Source DB:  PubMed          Journal:  Cardiology        ISSN： 0008-6312            Impact factor:   1.869


× No keyword cloud information.
  4 in total

Review 1.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

2.  Hemodynamic effects of the D- and L-isomers of sotalol on normal myocardium.

Authors:  H M Hoffmeister; M Beyer; L Seipel
Journal:  Cardiovasc Drugs Ther       Date:  1991-12       Impact factor: 3.727

Review 3.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  A comparison of the cardiovascular effects of (+)-sotalol and (+/-)-sotalol following intravenous administration in normal volunteers.

Authors:  G D Johnston; M B Finch; J A McNeill; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.